Immatics (IMTX) Capital Expenditures (2019 - 2025)
Immatics' (IMTX) quarterly Capital Expenditures came in at -$1.1 million in Q4 2025, up 36.88% year-on-year from -$824903.9 in Q4 2024, and up 10.98% quarter-over-quarter from -$1.3 million in Q3 2025.
Immatics (IMTX) Capital Expenditures (2019 - 2025) Analysis & Trends
Immatics has disclosed Capital Expenditures across 7 years of filings, most recently posting -$1.1 million for Q4 2025.
- Capital Expenditures for Q4 2025 came in at -$1.1 million, up 36.88% year-over-year; the trailing twelve-month figure through Dec 2025 was -$7.2 million (up 58.95% YoY), and the FY2025 annual result was -$7.4 million, up 57.39% from the prior year.
- Capital Expenditures came in at -$1.1 million for Q4 2025 at Immatics, up from -$1.3 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $56.3 million in Q4 2023 to a low of -$11.6 million in Q2 2023.
- The 5-year median for Capital Expenditures is -$1.6 million (2025), against an average of $386663.4.
- Across the five-year window, Capital Expenditures jumped 545.09% in 2022 and slumped 1248.09% in 2023, its largest moves.
- Immatics' Capital Expenditures stood at -$2.1 million in 2021, then surged by 545.09% to $9.3 million in 2022, then soared by 504.3% to $56.3 million in 2023, then slumped by 103.18% to -$1.8 million in 2024, then jumped by 36.88% to -$1.1 million in 2025.
- The last three Capital Expenditures figures came in at -$1.1 million (Q4 2025), -$1.3 million (Q3 2025), and -$1.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -1.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.13 Mn |
| Dec 31, 2025 | -1.13 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -1.62 Mn |
| Jun 30, 2025 | -1.62 Mn |
| Mar 31, 2025 | -3.23 Mn |
| Mar 31, 2025 | -3.23 Mn |
| Dec 31, 2024 | -1.79 Mn |
| Dec 31, 2024 | -1.79 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -2.82 Mn |
| Jun 30, 2024 | -2.82 Mn |
| Mar 31, 2024 | -9.97 Mn |
| Mar 31, 2024 | -9.97 Mn |
| Dec 31, 2023 | 56.28 Mn |
| Dec 31, 2023 | 56.28 Mn |
| Sep 30, 2023 | -7.08 Mn |
| Sep 30, 2023 | -7.08 Mn |